| edit |
|
Chemokine (C-X-C motif) ligand 5
|
||||||||||||||
| Identifiers | ||||||||||||||
| Symbols | CXCL5; ENA-78; SCYB5 | |||||||||||||
| External IDs | OMIM: 600324 HomoloGene: 88672 | |||||||||||||
|
||||||||||||||
| RNA expression pattern | ||||||||||||||
|
|
||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 6374 | n/a | ||||||||||||
| Ensembl | ENSG00000163735 | n/a | ||||||||||||
| Uniprot | P42830 | n/a | ||||||||||||
| Refseq | NM_002994 (mRNA) NP_002985 (protein) |
n/a (mRNA) n/a (protein) |
||||||||||||
| Location | Chr 4: 75.08 - 75.08 Mb | n/a | ||||||||||||
| Pubmed search | [1] | n/a | ||||||||||||
Chemokine (C-X-C motif) ligand 5, also known as CXCL5, is a human gene.[1]
The protein encoded by this gene, CXCL5 is a small cytokine belonging to the CXC chemokine family that is also known as epithelial-derived neutrophil-activating peptide 78 (ENA-78). It is produced following stimulation of cells with the inflammatory cytokines interleukin-1 or tumor necrosis factor-alpha.[2] Expression of CXCL5 has also been observed in eosinophils, and can be inhibited with the type II interferon IFN-γ.[3] This chemokine stimulates the chemotaxis of neutrophils possessing angiogenic properties. It elicits these effects by interacting with the cell surface chemokine receptor CXCR2.[3] The gene for CXCL5 is encoded on four exons and is located on human chromosome 4 amongst several other CXC chemokine genes.[2][4] CXCL5 has been implicated in connective tissue remodelling.[3]
References
- ^ "Entrez Gene: CXCL5 chemokine (C-X-C motif) ligand 5". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6374.
- ^ a b Chang MS, McNinch J, Basu R, Simonet S (1994). "Cloning and characterization of the human neutrophil-activating peptide (ENA-78) gene". J. Biol. Chem. 269 (41): 25277–82. PMID 7929219. http://www.jbc.org/cgi/content/abstract/269/41/25277.
- ^ a b c Persson T, Monsef N, Andersson P, Bjartell A, Malm J, Calafat J, Egesten A (2003). "Expression of the neutrophil-activating CXC chemokine ENA-78/CXCL5 by human eosinophils". Clin. Exp. Allergy 33 (4): 531–7. doi:. PMID 12680872.
- ^ O'Donovan N, Galvin M, Morgan JG (1999). "Physical mapping of the CXC chemokine locus on human chromosome 4". Cytogenet. Cell Genet. 84 (1-2): 39–42. doi:. PMID 10343098.
Further reading
- Duchene J, Lecomte F, Ahmed S, Cayla C, Pesquero J, Bader M, Perretti M, Ahluwalia A (2007). "A novel inflammatory pathway involved in leukocyte recruitment: role for the kinin B1 receptor and the chemokine CXCL5.". J. Immunol. 179 (7): 4849–56. PMID 17878384.
- Walz A, Schmutz P, Mueller C, Schnyder-Candrian S (1997). "Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease.". J. Leukoc. Biol. 62 (5): 604–11. PMID 9365115.
- Struyf S, Proost P, Van Damme J (2004). "Regulation of the immune response by the interaction of chemokines and proteases.". Adv. Immunol. 81: 1–44. doi:. PMID 14711052.
- Walz A, Burgener R, Car B, et al. (1992). "Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8.". J. Exp. Med. 174 (6): 1355–62. doi:. PMID 1744577.
- Power CA, Furness RB, Brawand C, Wells TN (1995). "Cloning of a full-length cDNA encoding the neutrophil-activating peptide ENA-78 from human platelets.". Gene 151 (1-2): 333–4. doi:. PMID 7828901.
- Chang MS, McNinch J, Basu R, Simonet S (1994). "Cloning and characterization of the human neutrophil-activating peptide (ENA-78) gene.". J. Biol. Chem. 269 (41): 25277–82. PMID 7929219.
- Corbett MS, Schmitt I, Riess O, Walz A (1995). "Characterization of the gene for human neutrophil-activating peptide 78 (ENA-78).". Biochem. Biophys. Res. Commun. 205 (1): 612–7. doi:. PMID 7999089.
- Koch AE, Kunkel SL, Harlow LA, et al. (1994). "Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis.". J. Clin. Invest. 94 (3): 1012–8. doi:. PMID 8083342.
- Power CA, Clemetson JM, Clemetson KJ, Wells TN (1996). "Chemokine and chemokine receptor mRNA expression in human platelets.". Cytokine 7 (6): 479–82. doi:. PMID 8580362.
- Ahuja SK, Murphy PM (1996). "The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.". J. Biol. Chem. 271 (34): 20545–50. doi:. PMID 8702798.
- Keates S, Keates AC, Mizoguchi E, et al. (1997). "Enterocytes are the primary source of the chemokine ENA-78 in normal colon and ulcerative colitis.". Am. J. Physiol. 273 (1 Pt 1): G75–82. PMID 9252512.
- Wuyts A, Proost P, Lenaerts JP, et al. (1998). "Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.". Eur. J. Biochem. 255 (1): 67–73. doi:. PMID 9692902.
- Wyrick PB, Knight ST, Paul TR, et al. (1999). "Persistent chlamydial envelope antigens in antibiotic-exposed infected cells trigger neutrophil chemotaxis.". J. Infect. Dis. 179 (4): 954–66. doi:. PMID 10068592.
- Wuyts A, Govaerts C, Struyf S, et al. (1999). "Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms.". Eur. J. Biochem. 260 (2): 421–9. doi:. PMID 10095777.
- Hogaboam CM, Bone-Larson CL, Steinhauser ML, et al. (1999). "Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines.". Faseb J. 13 (12): 1565–74. PMID 10463948.
- Luu NT, Rainger GE, Nash GB (2000). "Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils.". J. Immunol. 164 (11): 5961–9. PMID 10820279.
- Crane IJ, Wallace CA, McKillop-Smith S, Forrester JV (2000). "Control of chemokine production at the blood-retina barrier.". Immunology 101 (3): 426–33. doi:. PMID 11106948.
- Zhang C, Thornton MA, Kowalska MA, et al. (2001). "Localization of distal regulatory domains in the megakaryocyte-specific platelet basic protein/platelet factor 4 gene locus.". Blood 98 (3): 610–7. doi:. PMID 11468158.
- Chandrasekar B, Melby PC, Sarau HM, et al. (2003). "Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway.". J. Biol. Chem. 278 (7): 4675–86. doi:. PMID 12468547.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:. PMID 12477932.
 |
This article on a gene on chromosome 4 is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
